Evidence map›Paper›PMID 37110660›Full record

ArticleMolecules (Basel, Switzerland)2023

Secondary Metabolites from

Yufan Meng, Maosheng Zhang, Yike Fang, Jianwen Yang, Minjian Dong, Chengxin Sun, Shiji Xiao

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yufan MengKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.ORCID 0000-0003-3508-1069
Maosheng ZhangKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Yike FangKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Jianwen YangKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Minjian DongKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.ORCID 0000-0002-5180-4514
Chengxin SunKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.ORCID 0000-0001-7186-2917
Shiji XiaoKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Zunyi Medical University · CN

Funding

Cultivating New Academic Talents and Exploring Innovation Special Foundation of Zunyi Medical University QianKePingTai 2020-007National Natural Sciences Foundation of China 82060706Science and Technology Department of Guizhou Province QKHJC[2020]1Y402, QKHZC[2020]4Y211, QSKH2019003-005Zunyi Science and Technology Bureau ZSKH[2021]-281, ZSKH[2019]-16
6 · The paper itself

Abstract

To identify potential drug candidates, secondary metabolites of

Indexed as

DendrobiumApoptosisHumansapoptosisDendrobium nobileMAPKmoscatilin

Identifiers

PMID37110660
PMCPMC10145760
OpenAlexW4365454191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.